The aim of the IMplications for Sequencing of biologic therapy and choice of second Anti‐TNF in patients with IBD (IMSAT) study was to evaluate the relationship between immunogenicity to the first anti‐TNF therapy and immunogenicity and drug persistence to second anti‐TNF therapy. Here, TNF is linked to inflammatory bowel disease.